체외수정시술시 정상 난소 반응 예측 환자에서 Gonadotropin-releasing hormone antagonist와agonist의 효용성에 관한 연구

키워드

참고문헌 (37)

1. "Birth after the reimplantation of a human embryo", 2, pp.366~ (1978)
2. "Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins", 2, pp.1284~1285 (1984)
3. "Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression", 45, pp.226~230 (1986)
4. "The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer:a meta- analysis of randomized controlled trials", 58, pp.888~896 (1992)
5. "Optimal protocol for gonadotropin releasing hormone agonist use in ovarian stimulation", pp.405~410 (1997)
6. "Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks", 14, pp.2681~2686 (1999)
7. "The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres", 7(1), pp.49~66 (1992)
8. "Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome", 64, pp.568~572 (1995)
9. "Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation", 16, pp.644~651 (2001)
10. "Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase", 7, pp.930~933 (1992)
11. "Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation", 9, pp.788~791 (1994)
12. "The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program", 62, pp.468~476 (1994)
13. "Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study", 10, pp.1382~1386 (1995)
14. "Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone- releasing hormone(LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin", 15, pp.526~531 (2000)
15. "Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial", 15, pp.1490~1498 (2000)
16. "Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation", 75, pp.38~45 (2001)
17. "Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone- releasing hormone(LH-RH) antagonist(cetrorelix) or a depot formula of an LH-RH agonist(triptorelin)", 73, pp.314~320 (2000)
18. "체외수정시술시 다태임신의 예방에 관한 연구:배아 등급과 누적배아지수의 의의", 38, pp.2333~2346 (1995)
19. "고식적 체외수정시술시 3일째 배아이식술의 효용성에 관한 연구", 42, pp.457~463 (1999)
20. "난자 세포질내 정자 주입술을 이용한 체외수정시술시 누적 임신율에 관한 연구", 44, pp.492~500 (2001)
21. "체외수정시술시 5일간의 체외배양을 이용한 포배기 배아 이식술에 관한 연구", 44, pp.2000~2009 (2001)
22. "Gonadotrophin-releasing hormone antagonists for assisted conception", 4, pp.CD001750~ (2001)
23. ". Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis", 265, pp.175~182 (2001)
24. "A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix(Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon)", 13, pp.3023~3031 (1998)
25. "The use of a GnRH antagonist(Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg", 13, pp.2411~2414 (1998)
26. "Clinical gynecologic endocrinology and infertility", pp.1113~ (1999)
27. "Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women", 9, pp.1237~1242 (1994)
28. "Gene expression of gonadotropin-releasing hormone, but not its receptor, in human endometrium and decidua", 135, pp.165~168 (1997)
29. "Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells", 172, pp.1518~1525 (1995)
30. "Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists", 15, pp.1211~1216 (2000)
31. "Significant reduction of the incidence of ovarian hyperstimulation syndrome(OHSS) by using the LHRH antagonist Cetrorelix(Cetrotide) in controlled ovarian stimulation for assisted reproduction", 264, pp.29~32 (2000)
32. "Triggering of ovulation by a gonadotropin-releasing hormone(GnRH) agonist in patients pretreated with a GnRH antagonist", 66, pp.151~153 (1996)
33. "Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy", 79, pp.873~880 (2003)
34. "GnRH antagonists in normal-responder patients", 80(1), pp.8~15 (2003)
35. "Antagonists in poor-responder patients", 80(1), pp.16~24 (2003)
36. "GnRH antagonists for treatment of polycystic ovarian syndrome", 80(1), pp.25~31 (2003)
37. "Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist a pilot study with minimal stimulation", 14, pp.683~688 (1999)

관련 논문AI추천